IRIS UniCatt

Ciccarese, Chiara
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 603
NA - Nord America 447
EU - Europa 294
SA - Sud America 193
AF - Africa 23
Totale 1.560
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 423
SG - Singapore 246
BR - Brasile 168
CN - Cina 151
SE - Svezia 71
IN - India 55
IT - Italia 53
DE - Germania 48
VN - Vietnam 44
FR - Francia 27
GB - Regno Unito 23
BD - Bangladesh 18
IE - Irlanda 18
ID - Indonesia 16
HK - Hong Kong 14
MX - Messico 14
KR - Corea 13
PL - Polonia 12
RU - Federazione Russa 11
IQ - Iraq 10
CA - Canada 9
AR - Argentina 7
JP - Giappone 7
ZA - Sudafrica 7
EC - Ecuador 6
ES - Italia 6
TR - Turchia 6
EG - Egitto 5
NL - Olanda 5
UA - Ucraina 5
AE - Emirati Arabi Uniti 4
SA - Arabia Saudita 4
VE - Venezuela 4
CL - Cile 3
DZ - Algeria 3
FI - Finlandia 3
LT - Lituania 3
MM - Myanmar 3
CI - Costa d'Avorio 2
CO - Colombia 2
JO - Giordania 2
KE - Kenya 2
MA - Marocco 2
PY - Paraguay 2
AL - Albania 1
AT - Austria 1
BG - Bulgaria 1
BY - Bielorussia 1
CY - Cipro 1
CZ - Repubblica Ceca 1
ET - Etiopia 1
IR - Iran 1
IS - Islanda 1
KG - Kirghizistan 1
LB - Libano 1
LU - Lussemburgo 1
MD - Moldavia 1
NP - Nepal 1
PA - Panama 1
PH - Filippine 1
PK - Pakistan 1
PS - Palestinian Territory 1
RS - Serbia 1
SR - Suriname 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
UZ - Uzbekistan 1
Totale 1.560
Salva come PNG Salva come JPEG
Città #
Singapore 98
Ashburn 62
Chandler 43
Hefei 38
Hyderabad 34
Beijing 32
Frankfurt am Main 23
Ho Chi Minh City 21
Los Angeles 20
São Paulo 19
Dublin 18
New York 15
Hong Kong 14
Seoul 13
Jakarta 12
Milan 11
Rome 11
The Dalles 11
Kent 10
Düsseldorf 9
Hanoi 9
Brooklyn 8
Chennai 8
Chicago 8
Mexico City 8
Warsaw 8
Johannesburg 7
Tokyo 7
Boston 6
Dallas 6
Denver 6
Dhaka 6
Houston 6
Orem 6
Poplar 6
Porto Alegre 6
Princeton 6
Curitiba 5
Dearborn 5
Munich 5
Santa Clara 5
Seattle 5
Ankara 4
Atlanta 4
Baghdad 4
Falkenstein 4
Moscow 4
Nanjing 4
Portsmouth 4
Rio de Janeiro 4
Stockholm 4
Wilmington 4
Belo Horizonte 3
Bexley 3
Buffalo 3
Cairo 3
Guayaquil 3
Hebei 3
Jeddah 3
Montreal 3
Querétaro 3
Redwood City 3
San Mateo 3
Secaucus 3
São Gonçalo 3
Uberlândia 3
Abidjan 2
Alghero 2
Amman 2
Amsterdam 2
Berlin 2
Boardman 2
Brescia 2
Canaã dos Carajás 2
Cleveland 2
Concord 2
Cruzeiro 2
Da Nang 2
Dubai 2
Duncan 2
Erbil 2
Greensboro 2
Guaratinguetá 2
Haiphong 2
Hải Dương 2
Lappeenranta 2
Lauterbourg 2
Maceió 2
Medellín 2
Messina 2
Mumbai 2
Mérida 2
Nairobi 2
Nuremberg 2
Phoenix 2
Praia Grande 2
Quận Tân Phú 2
Recife 2
Salerno 2
San Bernardo 2
Totale 806
Salva come PNG Salva come JPEG
Nome #
Going towards a precise definition of the therapeutic management of de-novo metastatic castration sensitive prostate cancer patients: How prognostic classification impact treatment decisions 98
Biomarkers of response to advanced prostate cancer therapy 96
Prognostic Significance of Grade Discrepancy Between Primary Tumor and Venous Thrombus in Nonmetastatic Clear-cell Renal Cell Carcinoma: Analysis of the REMEMBER Registry and Implications for Adjuvant Therapy 94
Theranostics revolution in prostate cancer: Basics, clinical applications, open issues and future perspectives 92
PD-L1 Expression in de Novo Metastatic Castration-sensitive Prostate Cancer 92
Targeting hypoxia-inducible factor pathways in sporadic and Von Hippel-Lindau syndrome-related kidney cancers 87
Cabozantinib-related cardiotoxicity: a prospective analysis in a real-world cohort of metastatic renal cell carcinoma patients 84
Cabozantinib-related pneumothorax in rapidly responding patients with renal cell carcinoma 80
Management of metastatic urothelial carcinoma: Current approach, emerging agents, and future perspectives 77
Prostate cancer heterogeneity: Discovering novel molecular targets for therapy 76
Comparison of PIV and Other Immune Inflammation Markers of Oncological and Survival Outcomes in Patients Undergoing Radical Cystectomy 74
Avelumab Plus Intermittent Axitinib in Previously Untreated Patients with Metastatic Renal Cell Carcinoma. The Tide-A Phase 2 Study 69
Current evidence for second-line treatment in metastatic renal cell carcinoma after progression to immune-based combinations 68
The incidence and relative risk of major adverse cardiovascular events and hypertension in patients treated with immune checkpoint inhibitors plus tyrosine-kinase inhibitors for solid tumors: a systemic review and meta-analysis 65
New first-line immunotherapy-based combinations for metastatic renal cell carcinoma: A systematic review and network meta-analysis 62
Triplet therapy with androgen deprivation, docetaxel, and androgen receptor signalling inhibitors in metastatic castration-sensitive prostate cancer: A meta-analysis 62
Revising PTEN in the era of immunotherapy: New perspectives for an old story 58
Post nephrectomy management of localized renal cell carcinoma. From risk stratification to therapeutic evidence in an evolving clinical scenario 57
Efficacy of VEGFR-TKIs plus immune checkpoint inhibitors in metastatic renal cell carcinoma patients with favorable IMDC prognosis 54
Patients with sarcomatoid renal cell carcinoma – re-defining the first-line of treatment: A meta-analysis of randomised clinical trials with immune checkpoint inhibitors 53
First-line avelumab for patients with PD-L1-positive metastatic or locally advanced urothelial cancer who are unfit for cisplatin 51
Diagnostic Biopsy for Small Renal Tumours: A Survey of Current European Practice 42
Totale 1.591
Salva come PNG Salva come JPEG
Categoria #
all - tutte 6.945
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.945
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211 0 0 0 0 0 0 0 0 1 0 0 0
2021/202245 4 0 3 4 6 0 0 6 1 1 14 6
2022/2023135 26 22 8 12 15 8 9 12 14 1 3 5
2023/202498 6 21 3 11 4 11 4 0 7 3 13 15
2024/2025456 3 1 16 8 6 9 47 17 45 83 103 118
2025/2026814 199 64 84 200 220 47 0 0 0 0 0 0
Totale 1.591